Anupam Rasayan India Limited Reports Q1FY25 Results

5, NSE- ANURAS, ISIN: INE930P01018), one of India’s leading custom synthesis and specialty chemical player, has announced its financial results for the quarter ended June 30, 2024.

Consolidated Financial Highlights for quarter ended June 30, 2024:

§   Total revenue for Q1FY25 was at ₹2,603 million as compared to ₹3,988 million in Q1FY24.

§   EBITDA (incl. other income) was at ₹592 million in Q1FY25 as compared to ₹1,138 million in Q1FY24, this would translate into 23% EBITDA margin in this quarter.

§   Profit After Tax was at ₹122 million in Q1FY25 as compared to ₹523 million in Q1FY24.

Speaking on theAnupam Rasayan India Limited Reports Q1FY25 Results

                                       Q1FY25 Total Revenue of ₹2,603 Mn; EBITDA Margin at 23%

Surat, August 13, 2024: Anupam Rasayan India Ltd. (BSE- 543275, NSE- ANURAS, ISIN: INE930P01018), one of India’s leading custom synthesis and specialty chemical player, has announced its financial results for the quarter ended June 30, 2024.

Consolidated Financial Highlights for quarter ended June 30, 2024:

§   Total revenue for Q1FY25 was at ₹2,603 million as compared to ₹3,988 million in Q1FY24.

§   EBITDA (incl. other income) was at ₹592 million in Q1FY25 as compared to ₹1,138 million in Q1FY24, this would translate into 23% EBITDA margin in this quarter.

§   Profit After Tax was at ₹122 million in Q1FY25 as compared to ₹523 million in Q1FY2

Speaking on the performance, Mr Anand Desai, Managing Director, Anupam Rasayan commented, “Agro chemical industry is facing significant headwinds since last one year. We anticipate this trend to persist until the end of H1FY25, after which we expect demand to strengthen. This coupled with our polymer and pharma segment ramping up, we expect our revenue growth to come back from H2FY25.

Our consolidated operating revenue for the quarter stood at ₹254 crores with a YoY de-growth of 34%. The EBITDA margin was at 23% in Q1FY25. Compression in the EBITDA margins was largely due to the lower volumes offtake for the quarter. We expect this number to normalize as the volume picks up in the later half of the year.

We expect all our plants to be commercialized this year. With the new capacity, ramp-up of the recently launched Fluorinated molecules and LOIs & Contracts we had signed, we expect robust growth over the medium term.

About Anupam Rasayan India Ltd. (ARIL):

Anupam Rasayan India Ltd (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Incorporated in 1984, the speciality chemicals major has two verticals: Life science related Specialty Chemicals comprising products related to Agrochemicals, Personal Care and Pharmaceuticals, Other Specialty Chemicals comprising Polymer Additives. The Company caters to a diverse base of Indian and global customers. It is currently manufacturing products for over 75 domestic and international customers, including 31 multinational companies. The Company operates via its six manufacturing facilities in Gujarat, India, with four facilities located at Sachin, Surat and two located at Jhagadia, Bharuch with an aggregate installed capacity of about 27,000 MT, as of March 31, 2024. ARIL offers multistep synthesis and undertakes complex chemical reactions technologies, for a diverse base of Indian and global customers. The Company is focussed on developing in-house innovative processes for manufacturing products requiring complex chemistries and achieving cost optimization.

About Anupam Rasayan India Ltd. (ARIL):

Anupam Rasayan India Ltd (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Incorporated in 1984, the speciality chemicals major has two verticals: Life science related Specialty Chemicals comprising products related to Agrochemicals, Personal Care and Pharmaceuticals, Other Specialty Chemicals comprising Polymer Additives. The Company caters to a diverse base of Indian and global customers. It is currently manufacturing products for over 75 domestic and international customers, including 31 multinational companies. The Company operates via its six manufacturing facilities in Gujarat, India, with four facilities located at Sachin, Surat and two located at Jhagadia, Bharuch with an aggregate installed capacity of about 27,000 MT, as of March 31, 2024. ARIL offers multistep synthesis and undertakes complex chemical reactions technologies, for a diverse base of Indian and global customers. The Company is focussed on developing in-house innovative processes for manufacturing products requiring complex chemistries and achieving cost optimization.